| MF： | C19H29Cl3N2 |
| MW： | 391.80596 |
purity: 98%+
Venetoclax is used alone or in combination with obinutuzumab (Gazyva) or rituximab (Rituxan) to treat certain types of chronic lymphocytic leukemia or certain types of small lymphocytic lymphoma (SLL; a type of cancer that begins mostly in the lymph nodes).
Check that your browser version is too low，
In order not to affect the normal use of the site, please directly upgrade your browser, or use other browsers such as: firefox, Google.
